XML 61 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of fair value of options granted
   Employee   Non-Employee 
Expected volatility   88.1%   N/A 
Expected dividend yield       N/A 
Expected term (in years)   5    N/A 
Risk-free interest rate   0.26%   N/A 
Schedule of stock option activity
   Number of
Options
   Weighted
Average
Exercise
Price Per
Share
   Weighted
Average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value (1)
 
Outstanding at December 31, 2019   136,489   $28.00    3.9   $ 
Granted   25,000   $2.44    4.8   $ 
Exercised      $       $ 
Forfeited   (6,000)  $       $ 
Expired      $       $ 
Outstanding at June 30, 2020   155,489   $24.83    3.9   $ 
Exercisable at June 30, 2020   99,573   $28.22    2.5   $ 

 

(1) The aggregate intrinsic value in the table was calculated based on the difference between the estimated fair market value of the Company's stock and the exercise price of the underlying options. The estimated stock values used in the calculation were $2.00 and $11.00 per share for the six months ended June 30, 2020 and the year ended December 31, 2019, respectively.
Schedule of summarizes restricted stock unit activity
   Number of
Units
   Weighted Average
Grant-Date Fair
Value Per Unit
 
Outstanding as of December 31, 2019   5,877   $30.28 
Granted      $ 
Vested   (4,543)  $1.42 
Forfeited      $ 
Outstanding as of June 30, 2020   1,334   $1.80 
Schedule of stock-based compensation expense
  Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2020   2019   2020   2019 
                 
Research and development  $2   $1   $5   $10 
General and administrative   138    218    286    461 
Total stock-based compensation expense  $140   $219   $291   $471